메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 30, Issue 2, 2012, Pages
Takotsubo cardiomyopathy and fluorouracil: Case report and review of the literature
Author keywords

[No Author keywords available]
Indexed keywords

ACETYLSALICYLIC ACID; CAPECITABINE; CARVEDILOL; FLUOROURACIL; FOLINIC ACID; FUROSEMIDE; LISINOPRIL; OXALIPLATIN; SIMVASTATIN;
EID: 84855568574     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.38.5278     Document Type: Article
Times cited : (67)
References (20)
  • 1
    • 0032950467 scopus 로고    scopus 로고
    • Cardiotoxicity of the antiproliferative compound fluorouracil
    • DOI 10.2165/00003495-199957040-00003
    • Becker K, Erckenbrecht JF, Häussinger D, et al: Cardiotoxicity of the antiproliferative compound fluorouracil. Drugs 57:475-484, 1999 (Pubitemid 29196916)
    • (1999) Drugs , vol.57 , Issue.4 , pp. 475-484
    • Becker, K.1    Erckenbrecht, J.F.2    Haussinger, D.3    Frieling, T.4
  • 4
    • 57349189383 scopus 로고    scopus 로고
    • The spectrum of 5-fluorouracil cardiotoxicity
    • Dalzell JR, Samuel LM: The spectrum of 5-fluorouracil cardiotoxicity. Anticancer Drugs 20:79-80, 2009
    • (2009) Anticancer Drugs , vol.20 , pp. 79-80
    • Dalzell, J.R.1    Samuel, L.M.2
  • 6
    • 0027202039 scopus 로고
    • In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle
    • Mosseri M, Fingert HJ, Varticovski L, et al: In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle. Cancer Res 53:3028-3033, 1993 (Pubitemid 23210307)
    • (1993) Cancer Research , vol.53 , Issue.13 , pp. 3028-3033
    • Mosseri, M.1    Fingert, H.J.2    Varticovski, L.3    Chokshi, S.4    Isner, J.M.5
  • 9
    • 79955524981 scopus 로고    scopus 로고
    • 5-Fluorouracil-induced acute dilated cardiomyopathy in a pediatric patient
    • Radhakrishnan V, Bakhshi S: 5-Fluorouracil-induced acute dilated cardiomyopathy in a pediatric patient. J Pediatr Hematol Oncol 33:323, 2011
    • (2011) J Pediatr Hematol Oncol , vol.33 , pp. 323
    • Radhakrishnan, V.1    Bakhshi, S.2
  • 10
  • 11
    • 0033767273 scopus 로고    scopus 로고
    • Acute reversible cardiomyopathy and thromboembolism after cisplatin and 5-fluorouracil chemotherapy: A case report
    • Cheriparambil KM, Vasireddy H, Kuruvilla A, et al: Acute reversible cardiomyopathy and thromboembolism after cisplatin and 5-fluorouracil chemotherapy: A case report. Angiology 51:873-878, 2000
    • (2000) Angiology , vol.51 , pp. 873-878
    • Cheriparambil, K.M.1    Vasireddy, H.2    Kuruvilla, A.3
  • 12
    • 77951096208 scopus 로고    scopus 로고
    • Cardiotoxicity with 5-fluorouracil and capecitabine: More than just vasospastic angina
    • Stewart T, Pavlakis N, Ward M: Cardiotoxicity with 5-fluorouracil and capecitabine: More than just vasospastic angina. Intern Med J 40:303-307, 2010
    • (2010) Intern Med J , vol.40 , pp. 303-307
    • Stewart, T.1    Pavlakis, N.2    Ward, M.3
  • 13
    • 67649556029 scopus 로고    scopus 로고
    • 5 Flourouracil-induced apical ballooning syndrome: A case report
    • Gianni M, Dentali F, Lonn E: 5 flourouracil-induced apical ballooning syndrome: A case report. Blood Coagul Fibrinolysis 20:306-308, 2009
    • (2009) Blood Coagul Fibrinolysis , vol.20 , pp. 306-308
    • Gianni, M.1    Dentali, F.2    Lonn, E.3
  • 14
    • 63149183887 scopus 로고    scopus 로고
    • A case of Takotsubo cardiomyopathy during 5-fluorouracil treatment for rectal adenocarcinoma
    • Kobayashi N, Hata N, Yokoyama S, et al: A case of Takotsubo cardiomyopathy during 5-fluorouracil treatment for rectal adenocarcinoma. J Nihon Med Sch 76:27-33, 2009
    • (2009) J Nihon Med Sch , vol.76 , pp. 27-33
    • Kobayashi, N.1    Hata, N.2    Yokoyama, S.3
  • 18
    • 85171902538 scopus 로고    scopus 로고
    • 5-Fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity
    • epub ahead of print on May 21
    • Jensen SA, Sørensen JB: 5-Fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity. Cancer Chemother Pharmacol [epub ahead of print on May 21, 2011]
    • (2011) Cancer Chemother Pharmacol
    • Jensen, S.A.1    Sørensen, J.B.2
  • 19
    • 34547732827 scopus 로고    scopus 로고
    • Levosimendan: The inotrope of choice in cardiogenic shock secondary to takotsubo cardiomyopathy?
    • Padayachee L: Levosimendan: The inotrope of choice in cardiogenic shock secondary to takotsubo cardiomyopathy? Heart Lung Circ 16:S65-S70, 2007
    • (2007) Heart Lung Circ , vol.16
    • Padayachee, L.1
  • 20
    • 77049119270 scopus 로고    scopus 로고
    • Reduced estrogen in menopause may predispose women to takotsubo cardiomyopathy
    • Kuo BT, Choubey R, Novaro GM: Reduced estrogen in menopause may predispose women to takotsubo cardiomyopathy. Gend Med 7:71-77, 2010
    • (2010) Gend Med , vol.7 , pp. 71-77
    • Kuo, B.T.1    Choubey, R.2    Novaro, G.M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.